investigating the safety and efficacy of re-treating cll patients with venetoclax-based regimens
Published 1 year ago • 627 plays • Length 3:33Download video MP4
Download video MP3
Similar videos
-
1:36
improve study update: safety and efficacy of venetoclax retreatment in r/r cll
-
3:17
transcend-cll-004 study update: safety and efficacy of liso-cel in r/r cll
-
2:25
monitoring infection risk in patients with cll & insights into the prevent-acall trial
-
1:01
investigating the safety profile of enitociclib in patients with high-risk cll & richter's syndrome
-
4:38
venice i: venetoclax in r/r cll patients
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
0:49
venice ii trial: health-related qol in patients with cll treated with venetoclax
-
1:31
clinical outcomes are poor for cll patients treated with venetoclax post-btki exposure
-
5:54
laboratory investigation - vascular
-
9:41
subcutaneous epcoritamab in r/r b-cell non-hodgkin lymphoma
-
3:46
long-term follow-up of venetoclax in cll
-
2:00
obinutuzumab, ibrutinib, and venetoclax in high-risk cll: the cll2-give and cll13 trials
-
2:25
the safety & efficacy of copanlisib nivolumab in patients with rt and tnhl: a chemo-free approach
-
2:20
the effect of ibrutinib dose-reduction on outcomes of patients with cll/sll: real-world evidence
-
1:25
the management of cll in italy
-
3:03
outcomes following venetoclax monotherapy in patients with r/r wm in the real-world setting
-
4:02
elm-2: promising safety and efficacy of odronextamab in r/r dlbcl
-
2:43
veneto-stop: mrd detection by ngs to optimize treatment outcomes with venetoclax
-
5:54
updates from captivate: ibrutinib and venetoclax for cll
-
3:34
the incidence and clinical correlates of non-immune cytopenia at cll diagnosis
-
4:31
sequence of administration of ibrutinib with obinutuzumab in r/r cll patients
-
1:13
dr. jones on the safety of venetoclax in cll